JP2010513552A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513552A5
JP2010513552A5 JP2009543061A JP2009543061A JP2010513552A5 JP 2010513552 A5 JP2010513552 A5 JP 2010513552A5 JP 2009543061 A JP2009543061 A JP 2009543061A JP 2009543061 A JP2009543061 A JP 2009543061A JP 2010513552 A5 JP2010513552 A5 JP 2010513552A5
Authority
JP
Japan
Prior art keywords
cancer
group
hydrogen
halo
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009543061A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513552A (ja
JP5166441B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/087044 external-priority patent/WO2008076704A1/en
Publication of JP2010513552A publication Critical patent/JP2010513552A/ja
Publication of JP2010513552A5 publication Critical patent/JP2010513552A5/ja
Application granted granted Critical
Publication of JP5166441B2 publication Critical patent/JP5166441B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009543061A 2006-12-21 2007-12-11 癌治療用イミダゾリジノニルアミノピリミジン化合物 Expired - Fee Related JP5166441B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87130206P 2006-12-21 2006-12-21
US60/871,302 2006-12-21
PCT/US2007/087044 WO2008076704A1 (en) 2006-12-21 2007-12-11 Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer

Publications (3)

Publication Number Publication Date
JP2010513552A JP2010513552A (ja) 2010-04-30
JP2010513552A5 true JP2010513552A5 (cg-RX-API-DMAC10.html) 2011-01-27
JP5166441B2 JP5166441B2 (ja) 2013-03-21

Family

ID=39186811

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009543061A Expired - Fee Related JP5166441B2 (ja) 2006-12-21 2007-12-11 癌治療用イミダゾリジノニルアミノピリミジン化合物

Country Status (14)

Country Link
US (1) US8101628B2 (cg-RX-API-DMAC10.html)
EP (1) EP2125793B1 (cg-RX-API-DMAC10.html)
JP (1) JP5166441B2 (cg-RX-API-DMAC10.html)
KR (1) KR101088291B1 (cg-RX-API-DMAC10.html)
CN (1) CN101563342B (cg-RX-API-DMAC10.html)
AT (1) ATE479680T1 (cg-RX-API-DMAC10.html)
AU (1) AU2007334039B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0721045A2 (cg-RX-API-DMAC10.html)
CA (1) CA2671738A1 (cg-RX-API-DMAC10.html)
DE (1) DE602007008952D1 (cg-RX-API-DMAC10.html)
EA (1) EA016177B1 (cg-RX-API-DMAC10.html)
ES (1) ES2349169T3 (cg-RX-API-DMAC10.html)
MX (1) MX2009006634A (cg-RX-API-DMAC10.html)
WO (1) WO2008076704A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2125794T1 (sl) 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
EA016781B1 (ru) * 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds
CN108853111B (zh) * 2018-08-07 2020-06-05 浙江大学 一种组合物在制备治疗吉非替尼肝脏毒性药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
WO2004063192A1 (en) * 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
JP2007533602A (ja) * 2003-07-31 2007-11-22 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換ベンゾチオフェン化合物及びそれらの使用
AU2005316312B2 (en) 2004-12-17 2009-10-22 Amgen, Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) * 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
SI2125794T1 (sl) 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
EA016781B1 (ru) 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds

Similar Documents

Publication Publication Date Title
IL266563B (en) Heterocyclic compounds useful as pdk1 inhibitors
JP2010523670A5 (cg-RX-API-DMAC10.html)
JP2017095457A5 (cg-RX-API-DMAC10.html)
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
EP4242236A3 (en) Monoclonal antibodies against claudin-18 for treatment of cancer
JP2008044952A5 (cg-RX-API-DMAC10.html)
JP2011527666A5 (cg-RX-API-DMAC10.html)
JP2010501572A5 (cg-RX-API-DMAC10.html)
JP2012509265A5 (cg-RX-API-DMAC10.html)
WO2013166004A3 (en) Organic compositions to treat kras-related diseases
JP2012082227A5 (cg-RX-API-DMAC10.html)
JP2011500713A5 (cg-RX-API-DMAC10.html)
HUE037295T2 (hu) RNS készítmény nem-kissejtes tüdõrák (NSCLC) kezelésére
EP2311879A3 (en) Monoclonal antibodies against claudin-18 for treatment of cancer
WO2010094720A3 (en) Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists
RU2011124894A (ru) Триазолотиадиазоловый ингибитор протеинкиназы с-мет
PT3199180T (pt) Anticorpos epha3 para o tratamento de tumores sólidos
GB0510584D0 (en) Organic compounds
JP2007510667A5 (cg-RX-API-DMAC10.html)
JP2017526662A5 (cg-RX-API-DMAC10.html)
CY1112570T1 (el) Θεραπεια καρκινων με μετασταση
JP2012509279A5 (cg-RX-API-DMAC10.html)
JP2012526766A5 (cg-RX-API-DMAC10.html)
ZA200706919B (en) Pharmacogenomic markers for prognosis of solid tumors
MY141780A (en) 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics